These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22633301)

  • 1. Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS.
    Ukena C; Dobre D; Mahfoud F; Kindermann I; Lamiral Z; Tala S; Rossignol P; Turgonyi E; Pitt B; Böhm M; Zannad F
    J Card Fail; 2012 Jun; 18(6):439-45. PubMed ID: 22633301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
    Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
    Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
    N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
    Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R;
    Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS.
    O'Keefe JH; Abuissa H; Pitt B
    Diabetes Obes Metab; 2008 Jun; 10(6):492-7. PubMed ID: 17490427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial.
    Carillo S; Zhang Y; Fay R; Angioi M; Vincent J; Sutradhor SC; Ahmed A; Pitt B; Zannad F
    Arch Cardiovasc Dis; 2014 Mar; 107(3):149-57. PubMed ID: 24630753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
    Goyal A; Mehta SR; Díaz R; Gerstein HC; Afzal R; Xavier D; Liu L; Pais P; Yusuf S
    Circulation; 2009 Dec; 120(24):2429-37. PubMed ID: 19948980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of diabetes mellitus as a risk factor of acute myocardial infarction].
    Peng XR; Zhao YF; Zou DJ; Gu P
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):322-8. PubMed ID: 21672377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study).
    Stein PK; Deedwania P
    Am J Cardiol; 2009 Jun; 103(11):1495-9. PubMed ID: 19463505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.
    de Pouvourville G; Solesse A; Beillat M
    Arch Cardiovasc Dis; 2008 Sep; 101(9):515-21. PubMed ID: 19041835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
    Pitt B; White H; Nicolau J; Martinez F; Gheorghiade M; Aschermann M; van Veldhuisen DJ; Zannad F; Krum H; Mukherjee R; Vincent J;
    J Am Coll Cardiol; 2005 Aug; 46(3):425-31. PubMed ID: 16053953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.
    Dobre D; Rossignol P; Murin J; Parkhomenko A; Lamiral Z; Krum H; van Veldhuisen DJ; Pitt B; Zannad F
    Eur J Heart Fail; 2013 Feb; 15(2):221-7. PubMed ID: 22872593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.
    Gheorghiade M; Khan S; Blair JE; Harinstein ME; Krum H; Mukherjee R; Pitt B;
    Am Heart J; 2009 Sep; 158(3):437-43. PubMed ID: 19699868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
    Rossignol P; Ménard J; Fay R; Gustafsson F; Pitt B; Zannad F
    J Am Coll Cardiol; 2011 Nov; 58(19):1958-66. PubMed ID: 22032706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS).
    Chan PS; Soto G; Jones PG; Nallamothu BK; Zhang Z; Weintraub WS; Spertus JA
    Circulation; 2009 Jan; 119(3):398-407. PubMed ID: 19139382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
    Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of matrix metalloproteinase-9 plasma levels to identify patients with preserved left ventricular systolic function after acute myocardial infarction who could benefit from eplerenone.
    Kampourides N; Tziakas D; Chalikias G; Papazoglou D; Maltezos E; Symeonides D; Konstantinides S
    Am J Cardiol; 2012 Oct; 110(8):1085-91. PubMed ID: 22742718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudy.
    Regnault V; Lagrange J; Pizard A; Safar ME; Fay R; Pitt B; Challande P; Rossignol P; Zannad F; Lacolley P
    Hypertension; 2014 Jan; 63(1):105-11. PubMed ID: 24126172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
    Kosiborod M; Inzucchi SE; Krumholz HM; Xiao L; Jones PG; Fiske S; Masoudi FA; Marso SP; Spertus JA
    Circulation; 2008 Feb; 117(8):1018-27. PubMed ID: 18268145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
    Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Li Y; Li JD; Zhang Y; Liu LS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1230-3. PubMed ID: 19595174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.